Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Alimera
Alimera
Alimera, pSivida Strike Out On Eye Implant Drug
Seeking Alpha
Tue, 11/15/11 - 12:53 pm
Alimera
pSivida
diabetic macular edema
Iluvien
Alimera plunges as FDA asks for new Iluvien trials
Yahoo/AP
Sat, 11/12/11 - 12:33 pm
Alimera
Iluvien
pSivida
diabetic macular edema
Alimera Sciences Reports Third Quarter 2011 Financial Results
Yahoo
Fri, 11/4/11 - 09:22 am
earnings
Alimera
6 Biotech Stocks Analysts Expect To Double In 2012
Seeking Alpha
Wed, 11/2/11 - 11:53 am
Sequenom
Incyte
Novavax
Zalicus
YM BioSciences
Alimera
November Catalysts for Biotech and Drug Stocks
Minyanville
Mon, 10/31/11 - 11:34 am
FDA
Regeneron
Vertex
Pharmasset
pSivida
Alimera
Salix
Teva Pharmaceuticals
BioSante
Transcept
2 Healthcare Companies Expecting September Catalysts
Seeking Alpha
Thu, 09/1/11 - 08:03 am
Amarin
AMR101
Iluvien
Alimera
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
biotech
drug approvals
FDA
Eyelea
Regeneron
Dendreon
Provenge
NuPathe
Zelrix
Adcetris
Seattle Genetics
Soliris
Alexion
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
EXPAREL
Pacira
Roche
Zelboraf
Iluvien
Alimera
Bio-T-Gel
Teva Pharmaceuticals
BioSante
Zevalin
Spectrum
ruxolitinib
Incyte
Novartis
Pfizer
crizotinib
Antares
Anturol
Bydureon
Amlyin
Eli Lilly
Alkermes
AZ-004
Alexza
Corlux
Corcept Therapeutics
Affymax
Takeda
peginesatide
Levadex
MAP Pharmaceuticals
Alimera Sciences Appoints James R. Largent to Its Board of Directors
Mon, 08/1/11 - 05:01 pm
Alimera
Board of Directors
Management
More Hot Biotech Trades for Second Half 2011
TheStreet.com
Tue, 07/12/11 - 10:27 am
Targacept
Aveo Pharmaceutical
Threshold Pharmaceuticals
Raptor Pharmaceuticals
Vertex Pharmaceuticals
Soligenix
Spectrum Pharmaceuticals
NuPathe
Pharmasset
Incyte
Adventrx
Celsion
Alimera
GTx
Ariad Pharmaceuticals
pSivida, Alimera want FDA to give eye treatment another look | Regulatory roundup
Sat, 05/14/11 - 12:58 pm
pSivida
Alimera
FDA
Alimera makes new request for approval of eye drug
Yahoo/AP
Sat, 05/14/11 - 12:53 pm
Alimera
Iluvien
diabetic macular edema
Biotech Calendar: Key Dates for May
Seeking Alpha
Mon, 05/2/11 - 12:42 pm
biotech
Columbia Laboratories
KV Pharmaceutical
Dendreon
Vertex Pharmaceuticals
MannKind
Alimera
Merck
NPS Pharmaceuticals
Ironwood
BioMimetic Therapeutics
Lexicon Pharmaceuticals
Avanir
Optimer
JNJ
Low-Priced Biotech Stocks With Insider Buying
Seeking Alpha
Sat, 03/19/11 - 10:06 am
Ligand
Dyax
Bioclinica
Synta Pharmaceuticals
Threshold Pharmaceuticals
Chelsea Therapeutics
Alimera
Cerus
3 Biotech 2010 IPOs Worthy of a Look
Motley Fool
Sun, 01/2/11 - 11:34 am
biotech
Pacific Biosciences
Alimera
Aveo Pharmaceutical
Biogen Idec
tivozanib
kidney cancer
DNA sequencing
Alimera Gets Unwelcome Christmas Message From FDA
Seeking Alpha
Mon, 12/27/10 - 08:22 am
Alimera
FDA
Iluvien
diabetic macular edema
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Mon, 12/13/10 - 12:26 pm
MannKind
Afrezza
Alimera
pSivida
Seattle Genetics
brentuximab vedotin
Illuvien
AstraZeneca
Zictifa
Clinical Data
Vilazodone
Orexigen
Contrave
Bristol-Myers Squibb
Yervoy
Pfizer
Protalix BioTherapeutics
UPLYSO
Xiafaxan
Salix
Human Genome Sciences
Benlysta
Dendreon
Provenge
InterMune
Esbriet
Cell Therapeutics
pixantrone
Forest Labs
Daxas
MELA Sciences
MelaFind
XenoPort
GSK
Horizant
Spectrum Pharmaceuticals
Fusilev
Adventrx
Vertex Pharmaceuticals
Telaprevir
Biotech Calendar: Key Dates for December
TheStreet.com
Tue, 11/30/10 - 09:20 am
Delcath
Arena Pharmaceuticals
RXi Pharmaceuticals
Cell Therapeutics
Amgen
Incyte
Celgene
Corcept Therapeutics
Affymax
Targacept
Exelixis
Orexigen
ONYX Pharmaceuticals
Seattle Genetics
MannKind
Alimera
AstraZeneca
Human Genome Sciences
2 Year-End FDA Run-Up Stock Plays
Seeking Alpha
Tue, 09/14/10 - 05:41 pm
FDA
pSivida
Alimera
Iluvien
Biotechs Avoiding the IPO Pool This Year -- Except for Profitable Ikaria
BNET Pharma
Tue, 05/18/10 - 09:39 am
IPOs
biotech
IkariaIronwood
Anthera
Trius Therapeutics
Aveo Pharmaceutical
Tengion
Alimera
Talecris
Codexis Sells IPO at Low End as Alimera Cuts Price
Businessweek
Thu, 04/22/10 - 10:22 am
IPOs
Codexis
Alimera
biotech
Pages
« first
‹ previous
1
2
3
next ›
last »